Kexin Kang

544 total citations
19 papers, 343 citations indexed

About

Kexin Kang is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Kexin Kang has authored 19 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Physiology and 2 papers in Pharmacology. Recurrent topics in Kexin Kang's work include Alzheimer's disease research and treatments (6 papers), Bioinformatics and Genomic Networks (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Kexin Kang is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Bioinformatics and Genomic Networks (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Kexin Kang collaborates with scholars based in China, United States and United Kingdom. Kexin Kang's co-authors include Ye‐Guang Chen, Mei Zhao, Zhike Zhou, Chuansheng Zhao, Xiaoqian Zhang, Shanshan Zhong, Xuechen Zhu, Qinghua Tao, Rongwei Zhang and Ying Xu and has published in prestigious journals such as The Journal of Cell Biology, Neuroscience & Biobehavioral Reviews and BioEssays.

In The Last Decade

Kexin Kang

18 papers receiving 341 citations

Peers

Kexin Kang
Ashley C. Knight United States
Anna Hammer Germany
David A. Hottman United States
Natalie Yuen United States
Sukhan Kim Denmark
Kexin Kang
Citations per year, relative to Kexin Kang Kexin Kang (= 1×) peers Yulan Sheng

Countries citing papers authored by Kexin Kang

Since Specialization
Citations

This map shows the geographic impact of Kexin Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kexin Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kexin Kang more than expected).

Fields of papers citing papers by Kexin Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kexin Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kexin Kang. The network helps show where Kexin Kang may publish in the future.

Co-authorship network of co-authors of Kexin Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Kexin Kang. A scholar is included among the top collaborators of Kexin Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kexin Kang. Kexin Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ye, Hua, et al.. (2025). Inhibition of RACGAP1 sensitizes triple-negative breast cancer cells to ferroptosis by regulating CPT1A-dependent fatty acid metabolism. Journal of Experimental & Clinical Cancer Research. 44(1). 323–323.
2.
Hong, Hong, Kexin Kang, Qing Guan, et al.. (2023). Cross-Talking Pathways of Rapidly Accelerated Fibrosarcoma-1 (RAF-1) in Alzheimer’s Disease. Molecular Neurobiology. 61(5). 2798–2807. 1 indexed citations
3.
Zhang, Xiaoyan, Kexin Kang, & Tom Wu. (2023). Synthesis and Self-assembly of a Novel Amphiphilic Tri-arm Star-shaped Copolymer Poly(ethylene oxide)-b-Poly(ε-caprolactone). Letters in Organic Chemistry. 20(10). 908–915. 1 indexed citations
4.
Zhang, Xiaoqian, Qu Li, Rui Zhan, et al.. (2023). Effect of physical activity on risk of Alzheimer's disease: A systematic review and meta-analysis of twenty-nine prospective cohort studies. Ageing Research Reviews. 92. 102127–102127. 19 indexed citations
5.
Kang, Kexin, Jun Bai, Shanshan Zhong, et al.. (2022). Down‐Regulation of Insulin Like Growth Factor 1 Involved in Alzheimer’s Disease via MAPK, Ras, and FoxO Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2022(1). 8169981–8169981. 16 indexed citations
6.
Kang, Kexin, et al.. (2022). Dishevelled phase separation promotes Wnt signalosome assembly and destruction complex disassembly. The Journal of Cell Biology. 221(12). 34 indexed citations
7.
Zhou, Zhike, Jun Bai, Shanshan Zhong, et al.. (2022). Downregulation of PIK3CB Involved in Alzheimer’s Disease via Apoptosis, Axon Guidance, and FoxO Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 1260161–1260161. 8 indexed citations
8.
Sun, Jingru, Kexin Kang, Yichuang Sun, Qinghui Hong, & Chunhua Wang. (2022). A multi-value 3D crossbar array nonvolatile memory based on pure memristors. The European Physical Journal Special Topics. 231(16-17). 3119–3130. 15 indexed citations
9.
Zhou, Zhike, Jun Bai, Shanshan Zhong, et al.. (2021). Integrative genomic analysis of PPP3R1 in Alzheimer’s disease: a potential biomarker for predictive, preventive, and personalized medical approach. The EPMA Journal. 12(4). 647–658. 8 indexed citations
10.
Kang, Kexin, et al.. (2021). Phase separation of Axin organizes the β-catenin destruction complex. The Journal of Cell Biology. 220(4). 75 indexed citations
11.
Zhou, Zhike, Jun Bai, Shanshan Zhong, et al.. (2021). Downregulation of ATP6V1A Involved in Alzheimer’s Disease via Synaptic Vesicle Cycle, Phagosome, and Oxidative Phosphorylation. Oxidative Medicine and Cellular Longevity. 2021(1). 5555634–5555634. 23 indexed citations
12.
Zhou, Zhike, Jun Bai, Shanshan Zhong, et al.. (2021). Integrative Functional Genomic Analysis of Molecular Signatures and Mechanistic Pathways in the Cell Cycle Underlying Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity. 2021(1). 5552623–5552623. 6 indexed citations
13.
Zhou, Zhike, Shanshan Zhong, Yifan Liang, et al.. (2021). Serum Uric Acid and the Risk of Dementia: A Systematic Review and Meta-Analysis. Frontiers in Aging Neuroscience. 13. 625690–625690. 26 indexed citations
14.
Zhou, Zhike, Shanshan Zhong, Rongwei Zhang, et al.. (2021). Functional analysis of brain derived neurotrophic factor (BDNF) in Huntington’s disease. Aging. 13(4). 6103–6114. 14 indexed citations
15.
Kang, Kexin, et al.. (2021). Liquid–liquid phase separation drives the β‐catenin destruction complex formation. BioEssays. 43(10). 11 indexed citations
16.
Zhou, Zhike, Yifan Liang, Xiaoqian Zhang, et al.. (2020). Fibrinogen and risk of dementia: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews. 112. 353–360. 14 indexed citations
17.
Zhou, Zhike, Yifan Liang, Xiaoqian Zhang, et al.. (2020). Low-Density Lipoprotein Cholesterol and Alzheimer's Disease: A Systematic Review and Meta-Analysis. Frontiers in Aging Neuroscience. 12. 5–5. 47 indexed citations
18.
Zhou, Zhike, Fenqin Chen, Shanshan Zhong, et al.. (2020). Molecular identification of protein kinase C beta in Alzheimer's disease. Aging. 12(21). 21798–21808. 11 indexed citations
19.
Zhou, Zhike, Yifan Liang, Xiaoqian Zhang, et al.. (2018). Plasma D-Dimer Concentrations and Risk of Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. Frontiers in Neurology. 9. 1114–1114. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026